Log in

ASX:SPLStarpharma Stock Price, Forecast & News

0.00 (0.00 %)
(As of 05/13/2020)
Today's Range
Now: A$1.00
50-Day Range
MA: A$0.94
52-Week Range
Now: A$1.00
Volume351,391 shs
Average Volume544,824 shs
Market Capitalization$372.54 million
P/E RatioN/A
Dividend YieldN/A
Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials for the treatment of a range of tumors, such as breast, prostate, and lung; and DEP cabazitaxel that is in Phase 1/2 clinical trial for solid tumors, as well as DEP irinotecan, an anti-cancer drug used to treat colorectal cancer. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual Sales$7.73 million
Cash FlowA$0.10 per share
Book ValueA$0.10 per share



Market Cap$372.54 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SPL News and Ratings via Email

Sign-up to receive the latest news and ratings for SPL and its competitors with MarketBeat's FREE daily newsletter.

Starpharma (ASX:SPL) Frequently Asked Questions

How has Starpharma's stock been impacted by COVID-19 (Coronavirus)?

Starpharma's stock was trading at A$0.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SPL stock has increased by 1.0% and is now trading at A$1.00. View which stocks have been most impacted by Coronavirus.

How were Starpharma's earnings last quarter?

Starpharma Holdings Limited (ASX:SPL) posted its quarterly earnings data on Wednesday, February, 27th. The company reported ($0.02) EPS for the quarter. View Starpharma's earnings history.

Has Starpharma been receiving favorable news coverage?

News stories about SPL stock have been trending very negative recently, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Starpharma earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutStarpharma.

Who are some of Starpharma's key competitors?

What other stocks do shareholders of Starpharma own?

Who are Starpharma's key executives?

Starpharma's management team includes the following people:
  • Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), MBA, GAICD, CEO, MD & Exec. Director (Age 56)
  • Mr. Nigel J. Baade, CFO & Company Sec.
  • Dr. A. Eglezos BSc(Hons), Ph.D., MBA, VP of Bus. Devel.
  • Dr. Jeremy R. Paull BSc (Hons), Ph.D., VP of Devel. & Regulatory Affairs
  • Dr. David J. Owen BSc(Hons) Ph.D., VP of Research

What is Starpharma's stock symbol?

Starpharma trades on the ASX under the ticker symbol "SPL."

What is Starpharma's stock price today?

One share of SPL stock can currently be purchased for approximately A$1.00.

How big of a company is Starpharma?

Starpharma has a market capitalization of $372.54 million and generates $7.73 million in revenue each year.

What is Starpharma's official website?

The official website for Starpharma is www.starpharma.com.

How can I contact Starpharma?

Starpharma's mailing address is 4-6 Southampton Cres, MELBOURNE, VIC 3067, Australia. The company can be reached via phone at +61-3-85322700.

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.